Stereotactic heart ablative radiotherapy (SHARP): a prospective multicentric phase II trial
The findings from this study may serve as a foundation for the future integration of cardiac SBRT into clinical practice guidelines for the management of cardiac malignancies.
Authors
- Christian M. Hagl
- Stefanie Corradini
- N. Andratschke
- Michael Reiner
- Panagiotis Balermpas (ORCID: https://orcid.org/0000-0001-5261-6446)
- Angela Romano (ORCID: https://orcid.org/0000-0001-9371-9951)
- Juliane Hörner‐Rieber (ORCID: https://orcid.org/0000-0003-3911-4438)
- Luca Boldrini (ORCID: https://orcid.org/0000-0002-5631-1575)
- S. Marschner
- Ludwig T. Weckbach (ORCID: https://orcid.org/0000-0002-0981-2246)
- Philipp Hoegen-Saßmannshausen
- Maximilian Niyazi
- Claus Belka
- Lars Lindner
- Nicola Fink
- Aurélie Gaasch
- Elisabetta Sandrini
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Agostino Gemelli University Polyclinic (IT)
- LMU Klinikum (DE)
- Düsseldorf University Hospital (DE)
- University Hospital of Zurich (CH)
- University Children's Hospital Tübingen (DE)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Heinrich Heine University Düsseldorf (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Strahlentherapie und Onkologie
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1007/s00066-026-02504-5
- Primary Topic
- Cardiac tumors and thrombi
- Type
- article
- Field-Weighted Citation Impact
- 0.00